Craig Stuart Millian, Chief Commercial Officer at Corbus Pharmaceuticals Holdings, Inc. (CRBP), bought 1,000 shares at $4.38 ($4K) on 2019-11-11, disclosed to the SEC on 2019-11-12.
Open-market purchase of $4k CRBP by Chief Commercial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| CRBP | BUY | 2020-03-18 | $9K | — | Filing → |
| CRBP | BUY | 2019-08-16 | $8K | — | Filing → |
| CRBP | BUY | 2019-08-13 | $9K | — | Filing → |